As a research center embedded within Kaiser Permanente’s large and dynamic health care system, our investigators have a unique opportunity to apply scientific expertise to real-world clinical problems, translate findings into practice, and share what we learn with the broader community.
Dr. Steven Jacobsen directs the research programs for Kaiser Permanente Southern California and the Department of Research & Evaluation, which has more than 30 faculty in epidemiology, health services, and related research. He serves as site principal investigator for the Vaccine Safety Datalink funded by the Centers for Disease Control and Prevention ...
New research shows that few women admitted to Kaiser Permanente Southern California hospitals to give birth this spring tested positive for COVID-19. Those who did were asymptomatic, and none passed on the infection to their newborns. “We had heard from our colleagues in New York about the high rate of COVID-19 among pregnant women coming ...
When she was a new scientist at Kaiser Permanente Southern California, Erin E. Hahn, PhD, MPH, had an intense interest in cancer research. Oncologists invited her into their quarterly meetings so she could see and hear the challenges they faced. One of those challenges was depression and anxiety among cancer patients. Dr. Hahn and others ...
Fifteen years ago when Matt Owen was a freshman psychology major in college, he had a “psychotic break from reality.” “I started having hallucinations that altered my mind in a way that dealing with everyday life became challenging,” he said. “It changed the course of my life.” Times were rocky for a while, including more ...
Department of Research & Evaluation Senior Research Scientist Jean M. Lawrence, ScD, MPH, MSSA, studies diabetes among women, children, and young adults. Why did you choose to devote your career to researching ways women and children can live better, healthier lives? I’ve always been interested in women’s and children’s health and started my career working ...
Receiving a cancer diagnosis can be a terrifying moment for a patient. But when patients at Kaiser Permanente Southern California see a physician for cancer, they can take comfort knowing they are also seeing a clinician researcher who can help them access the latest tools being studied for fighting the disease. “We are an integrated ...
The current edition of our IMPACT newsletter features stories about our clinical trials program, including launching clinical trials during the COVID-19 pandemic, integrating clinical trials into our stroke care, and sharing an overview of the program in the first of a new series of videos. Other stories highlight recent research into language concordance and heart attack trends. You will also meet our newest scientist!
The Division of Clinical Trials Research advances medical innovation by supporting evaluation of new drugs, therapies, and devices to prevent and treat health problems. Our physician investigators work with cooperative groups and industry sponsors to conduct clinical trials for investigational drugs, biologics, and devices. In addition, the division develops pragmatic trials that help answer questions about care delivery.
The region has clinical trials programs in oncology (adult, gynecologic, pediatric, and surgical/radiation oncology), urology, gynecology, neurology, dermatology, metabolic diseases, nephrology, ophthalmology, infectious disease, cardiology, hepatology, vascular surgery, and rheumatology. Clinical trials staff support trials at medical centers and medical office buildings throughout the Kaiser Permanente Southern California Region.
